Anhui Conch Cement Company Limited - AHCHY

AHCHY Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
AHCHY	0.4	-5	0.1	18.3	8.3	8.4	-44.1	-55.5	-15.7	26.4
S&P 500	-1.3	-1.8	1.0	5.9	10.6	30.4	25.4	88.1	187.6	33142.5

Compare AHCHY with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	AHCHY
name	Anhui Conch Cement Company Limited
price	13.49
changes percentage	0.37
change	0.05
day low	13.44
day high	13.49
year high	17.18
year low	9.82
market cap	18350033113
price avg 50	13.41
price avg 200	11.96
exchange	PNK
volume	11460
avg volume	19175
open	13.44
previous close	13.44
eps	0.91
pe	14.82
earnings announcement	2024-11-15T05:00:00.000+0000
shares outstanding	1360269319
timestamp	2024-11-14 20:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 47.0%

Overall Quarterly Financial Health: 61.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	139975249537	132021553710	6.02
gross profit	21354672051	28124383401	-24.07
gross profit ratio	0.15	0.21	-28.39
research and development expenses	1859553239	2011316648	-7.55
operating expenses	9983244567	11201067926	-10.87
interest income	2215460619	2217694942	-0.10
interest expense	929189849	524629199	77.11
ebitda	18813132580	26759563580	-29.70
ebitdaratio	0.13	0.21	-35.06
operating income	13137765626	19473671918	-32.54
operating income ratio	0.09	0.15	-36.37
net income	10430137630	15660749869	-33.40
net income ratio	0.07	0.12	-37.18
eps	1.97	14.8	-86.69

Overall Score of Annual Income Statement

0.12 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 139,975 million in 2023 from 132,022 million in 2022 representing a change of 6.02%. This indicates a sales growth, which is a positive sign for the company.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 21,355 million in 2023 from 28,124 million in 2022 representing a change of -24.07%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 1,860 million in 2023 from 2,011 million in 2022 representing a change of -7.55%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 9,983 million in 2023 from 11,201 million in 2022 representing a change of -10.87%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 18,813 million in 2023 from 26,760 million in 2022 representing a change of -29.7%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 13,138 million in 2023 from 19,474 million in 2022 representing a change of -32.54%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 10,430 million in 2023 from 15,661 million in 2022 representing a change of -33.4%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.97 in 2023 from 1.97 in 2022 representing a change of -86.69%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	22584738660	23975992063	-5.80
gross profit	4694144834	4290563016	9.41
gross profit ratio	0.21	0.18	16.15
research and development expenses	345800574	333458385	3.70
operating expenses	2330893975	2267229545	2.81
interest income	498434205	1588657881	-68.63
interest expense	611397563	-298116269	305.09
ebitda	3027068233	4159951874	-27.23
ebitdaratio	0.13	0.17	-20.44
operating income	2363250859	2023333470	16.80
operating income ratio	0.1	0.08	23.99
net income	1872817793	1823327162	2.71
net income ratio	0.08	0.08	9.04
eps	0.35	0.35	0.00

Overall Score of Quarterly Income Statement

0.57 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 22,585 million in 2024Q3 from 23,976 million in 2024Q2 representing a change of -5.8%. This indicates a sales shrinking, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 2,331 million in 2024Q3 from 2,267 million in 2024Q2 representing a change of 2.81%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 3,027 million in 2024Q3 from 4,160 million in 2024Q2 representing a change of -27.23%. The decrease in EBITDA indicates declined operational efficiency and profitability.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 4,694 million in 2024Q3 from 4,291 million in 2024Q2 representing a change of 9.41%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 346 million in 2024Q3 from 333 million in 2024Q2 representing a change of 3.7%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 2,363 million in 2024Q3 from 2,023 million in 2024Q2 representing a change of 16.8%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 1,873 million in 2024Q3 from 1,823 million in 2024Q2 representing a change of 2.71%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	246189199541	243976422237	0.91
total liabilities	48220471978	47982827505	0.50
total equity	197968727563	195993594732	1.01
cash and cash equivalents	68361599053	57865704190	18.14
short term investments	2210732788	10754921384	-79.44
long term investments	9168342468	-635780548	1,542.06
total current assets	101095916858	106018259536	-4.64
total non current assets	145093282683	137958162701	5.17
total current liabilities	29659828067	35571242686	-16.62
total non current liabilities	18560643911	12411584819	49.54
common stock	5299302579	5299302579	0.00
retained earnings	169028378766	166441208953	1.55
total debt	20289514598	22135122904	-8.34

Overall Score of Annual Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 246,189 million in 2023 from 243,976 million in 2022 representing a change of 0.91%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 197,969 million in 2023 from 195,994 million in 2022 representing a change of 1.01%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 68,362 million in 2023 from 57,866 million in 2022 representing a change of 18.14%. This indicates an increase in available liquid assets.

  Total Current Liabilities: Total Current Liabilities decreased to 29,660 million in 2023 from 35,571 million in 2022 representing a change of -16.62%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 169,028 million in 2023 from 166,441 million in 2022 representing a change of 1.55%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 20,290 million in 2023 from 22,135 million in 2022 representing a change of -8.34%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 48,220 million in 2023 from 47,983 million in 2022 representing a change of 0.5%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 2,211 million in 2023 from 10,755 million in 2022 representing a change of -79.44%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 101,096 million in 2023 from 106,018 million in 2022 representing a change of -4.64%. This indicates a worsen liquidity position.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	252090916161	243734511380	3.43
total liabilities	54103961187	46690517756	15.88
total equity	197986954974	196203888590	0.91
cash and cash equivalents	75025405902	67835470923	10.60
short term investments	1880888297	1669957543	12.63
long term investments	7562884464	9449989727	-19.97
total current assets	105244967169	97265946257	8.20
total non current assets	146845948992	146468565123	0.26
total current liabilities	28553447583	28692449432	-0.48
total non current liabilities	25550513604	17998068324	41.96
common stock	5299302579	5299302579	0.00
retained earnings	169136991697	167264173904	1.12
total debt	27795952086	25611967110	8.53

Overall Score of Quarterly Balance Sheet

0.78 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 252,091 million in 2024Q3 from 243,735 million in 2024Q2 representing a change of 3.43%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 197,987 million in 2024Q3 from 196,204 million in 2024Q2 representing a change of 0.91%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 75,025 million in 2024Q3 from 67,835 million in 2024Q2 representing a change of 10.6%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 1,881 million in 2024Q3 from 1,670 million in 2024Q2 representing a change of 12.63%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 105,245 million in 2024Q3 from 97,266 million in 2024Q2 representing a change of 8.2%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 28,553 million in 2024Q3 from 28,692 million in 2024Q2 representing a change of -0.48%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 169,137 million in 2024Q3 from 167,264 million in 2024Q2 representing a change of 1.12%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 54,104 million in 2024Q3 from 46,691 million in 2024Q2 representing a change of 15.88%. This indicates an increase in overall liabilities.

  Total Debt: Total Debt increased to 27,796 million in 2024Q3 from 25,612 million in 2024Q2 representing a change of 8.53%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-4607013618	-1239113981	-271.80
operating cash flow	21969464459	9649267916	127.68
free cash flow	7802013104	-16997027736	145.90
capital expenditure	-14167451355	-26646295652	46.83
depreciation and amortization	7445255106	6788947080	9.67
deferred income tax	-197671490	-182628410	-8.24
stock based compensation	0	182628410	-100.00
accounts payables	0	-3539926774	100.00
inventory	1580924625	-1711974063	192.35
acquisitions net	-1272643706	-1762966990	27.81
investments in property plant and equipment	-14167451355	-26646295652	46.83
net cash used for investing activites	-19307018000	-5280634362	-265.62
debt repayment	3483469000	7711907592	-54.83
common stock issued	0	0	NaN
common stock repurchased	-339160000	0	NaN
dividends paid	-8871243389	-12612340138	29.66
net cash used provided by financing activities	-4407925000	-5723457004	22.98
cash at end of period	11551409228	16158422846	-28.51
accounts receivables	5687324034	-5567114759	202.16
cash at beginning of period	16158422846	17397536827	-7.12

Overall Score of Annual Cashflow Statement

0.62 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -4,607 million in 2023 from -1,239 million in 2022 representing a change of -271.8%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure increased to -14,167 million in 2023 from -26,646 million in 2022 representing a change of 46.83%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Receivables: Accounts Receivables increased to 5,687 in 2023 from -5,567 million in 2022 representing a change of 202.16%. This suggests that the company is less capable of collecting payments from its customers.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 21,969 million in 2023 from 9,649 million in 2022 representing a change of 127.68%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 7,802 million in 2023 from -16,997 million in 2022 representing a change of 145.9%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2023 from 183 million in 2022 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2023 from 3,540 million in 2022 representing a change of 100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid increased to -8,871 million in 2023 from -12,612 million in 2022 representing a change of 29.66%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	0	6724692061	-100.00
free cash flow	-2711454473	3986319319	-168.02
capital expenditure	-2711454473	-2738372742	0.98
depreciation and amortization	0	2015942949	-100.00
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	0	2859382906	-100.00
accounts payables	0	0	NaN
inventory	0	-375251676	100.00
acquisitions net	-351635651	159287792	-320.75
investments in property plant and equipment	-2711454473	-2738372742	0.98
net cash used for investing activites	-5144716493	-783884056	-556.31
debt repayment	-5456696430	1768374987	-408.57
common stock issued	0	0	NaN
common stock repurchased	0	-161428057	100.00
dividends paid	-135405201	-5065977642	97.33
net cash used provided by financing activities	5772594145	-3547655915	262.72
net change in cash	4084033593	1498834869	172.48
cash at end of period	17942538963	67835470923	-73.55
cash at beginning of period	13858505370	66336636054	-79.11

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 4,084 million in 2024Q3 from 1,499 million in 2024Q2 representing a change of 172.48%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Accounts Receivables: Accounts Receivables decreased to 0 million in 2024Q3 from 2,859 million in 2024Q2 representing a change of -100.0%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -135 million in 2024Q3 from -5,066 million in 2024Q2 representing a change of 97.33%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 0 million in 2024Q3 from 6,725 million in 2024Q2 representing a change of -100.0%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -2,711 million in 2024Q3 from 3,986 million in 2024Q2 representing a change of -168.02%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -2,711 million in 2024Q3 from -2,738 million in 2024Q2 representing a change of 0.98%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	26.42	124.77	-78.83
net income per share	1.97	14.8	-86.70
operating cash flow per share	4.15	9.12	-54.53
free cash flow per share	1.47	-16.06	109.17
cash per share	13.32	64.85	-79.46
book value per share	37.36	185.22	-79.83
tangible book value per share	31.04	153.86	-79.83
shareholders equity per share	34.98	173.55	-79.85
interest debt per share	3.97	19.14	-79.27
market cap	433946197232.32	126188172433.66	243.89
enterprise value	385874112777.32	90457591147.66	326.58
pe ratio	41.61	8.06	416.34
price to sales ratio	3.1	0.96	224.35
pocfratio	19.75	13.08	51.04
pfcf ratio	55.62	-7.42	849.18
pb ratio	2.34	0.69	240.77
ptb ratio	2.34	0.69	240.77
ev to sales	2.76	0.69	302.34
enterprise value over ebitda	20.51	3.38	506.76
ev to operating cash flow	17.56	9.37	87.36
ev to free cash flow	49.46	-5.32	1,029.32
earnings yield	0.02	0.12	-80.63
free cash flow yield	0.02	-0.13	113.35
debt to equity	0.11	0.11	0.93
debt to assets	0.08	0.08	0.94
net debt to ebitda	-2.56	-1.34	-91.37
current ratio	3.41	2.98	14.36
interest coverage	14.14	37.12	-61.91
income quality	2.11	0.6	252.32
dividend yield	0.02	0.1	-79.55
payout ratio	0.85	0.81	5.61
sales general and administrative to revenue	0.01	0.01	-19.10
research and ddevelopement to revenue	0.01	0.02	-12.80
intangibles to total assets	0.14	0.14	0.12
capex to operating cash flow	0.64	2.76	-76.65
capex to revenue	0.1	0.2	-49.85
capex to depreciation	1.9	3.92	-51.52
stock based compensation to revenue	0	0.0	-100.00
graham number	39.36	240.4	-83.63
roic	0.05	0.08	-34.93
return on tangible assets	0.05	0.07	-33.99
graham net net	7.65	41.96	-81.77
working capital	71436088791	70447016850	1.40
tangible asset value	164441995701	162809300130	1.00
net current asset value	52875444880	58035432031	-8.89
invested capital	201709502123	193346524529	4.33
average receivables	20701085122.5	19244216651	7.57
average payables	6780621283.5	6910373854.5	-1.88
average inventory	10889670232.5	10787262810	0.95
days sales outstanding	45.65	66.06	-30.89
days payables outstanding	20.21	24.57	-17.73
days of inventory on hand	31.08	41.03	-24.25
receivables turnover	8.0	5.53	44.71
payables turnover	18.06	14.86	21.56
inventory turnover	11.74	8.9	32.02
roe	0.06	0.09	-34.00
capex per share	2.67	25.18	-89.38

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 41.61 on 2023-12-31 from 8.06 on 2022-12-31, representing a change of 416.34%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.11 on 2023-12-31 from 0.11 on 2022-12-31, representing a change of 0.93%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  Current Ratio: Current Ratio increased to 3.41 on 2023-12-31 from 2.98 on 2022-12-31, representing a change of 14.36%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
AHCHY
calendar year	2024	2024	NaN
revenue per share	4.27	4.54	-5.80
net income per share	0.35	0.35	2.71
operating cash flow per share	0	1.27	-100.00
free cash flow per share	-0.51	0.75	-168.02
cash per share	14.55	13.15	10.65
book value per share	37.47	37.29	0.48
tangible book value per share	31.08	30.91	0.56
shareholders equity per share	35.1	34.73	1.06
interest debt per share	5.34	4.65	14.72
market cap	532098337448.87	456563743970.15	16.54
enterprise value	484868883632.87	414340240157.15	17.02
pe ratio	71.03	62.6	13.46
price to sales ratio	23.56	19.04	23.72
pocfratio	0	67.89	-100.00
pfcf ratio	-196.24	114.53	-271.34
pb ratio	2.87	2.49	15.32
ptb ratio	2.87	2.49	15.32
ev to sales	21.47	17.28	24.23
enterprise value over ebitda	160.18	99.6	60.82
ev to operating cash flow	0	61.61	-100.00
ev to free cash flow	-178.82	103.94	-272.04
earnings yield	0.0	0.0	-11.87
free cash flow yield	-0.01	0.01	-158.36
debt to equity	0.15	0.14	9.72
debt to assets	0.11	0.1	7.21
net debt to ebitda	-15.6	-10.15	-53.72
current ratio	3.69	3.39	8.73
interest coverage	3.87	-6.79	156.95
income quality	0	3.69	-100.00
dividend yield	0.0	0.01	-97.71
payout ratio	0.07	2.78	-97.40
sales general and administrative to revenue	0.15	-0.02	792.87
research and ddevelopement to revenue	0.02	0.01	10.09
intangibles to total assets	0.13	0.14	-3.22
capex to operating cash flow	0	0.41	-100.00
capex to revenue	0.12	0.11	5.12
capex to depreciation	0	1.36	-100.00
stock based compensation to revenue	0	0	NaN
graham number	16.73	16.42	1.89
roic	0.01	0.01	17.55
return on tangible assets	0.01	0.01	-1.20
graham net net	5.16	6.71	-23.16
working capital	76691519586	68573496825	11.84
tangible asset value	164252313319	163343557456	0.56
net current asset value	51141005982	50575428501	1.12
invested capital	209234060292	200339189938	4.44
average receivables	4922999393	11591912852	-57.53
average payables	5739594855	6028745905.5	-4.80
average inventory	9715848371	10413128302	-6.70
days sales outstanding	0	36.96	-100.00
days payables outstanding	27.96	27.07	3.28
days of inventory on hand	44.78	48.15	-7.00
receivables turnover	0	2.44	-100.00
payables turnover	3.22	3.32	-3.18
inventory turnover	2.01	1.87	7.52
roe	0.01	0.01	1.63
capex per share	0.51	0.52	-0.98

• Negative

  ROE: Return on Equity (ROE) decreased to 0.01 on 2024-09-30 Q3 from 0.01 on 2024-06-30 Q2, representing a change of 1.63%. Suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 3.69 on 2024-09-30 Q3 from 3.39 on 2024-06-30 Q2, representing a change of 8.73%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 71.03 on 2024-09-30 Q3 from 62.60 on 2024-06-30 Q2, representing a change of 13.46%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.15 on 2024-09-30 Q3 from 0.14 on 2024-06-30 Q2, representing a change of 9.72%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 5.84 which is lower than current price 13.49, indicates the company may be overvalued.